The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation

References

• Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212. doi:10.1038/s41569-018-0119-4
   PubMed Web of Science ®Google Scholar
• Jimenez-Quevedo P, Serrador A, Perez de Prado A, et al. Spanish Cardiac Catheterization and Coronary Intervention Registry. 25th official report of the Spanish Society of Cardiology Working Group on cardiac catheterization and interventional cardiology (1990–2015). Rev Esp Cardiol. 2016;69(12):1180–1189. doi:10.1016/j.rec.2016.08.016
   PubMed Web of Science ®Google Scholar
• Peng N, Liu W, Li Z, et al. Drug-coated balloons versus everolimus-eluting stents in patients with in-stent restenosis: a pair-wise meta-analysis of randomized trials. Cardiovasc Ther. 2020;2020:1042329. doi:10.1155/2020/1042329
   PubMed Web of Science ®Google Scholar
• Piccolo R, Bonaa KH, Efthimiou O, et al. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019;393(10190):2503–2510. doi:10.1016/S0140-6736(19)30474-X
   PubMed Web of Science ®Google Scholar
• Chang CF, Lin CC. Current concepts of contrast-induced nephropathy: a brief review. J Chin Med Assoc. 2013;76(12):673–681. doi:10.1016/j.jcma.2013.08.011
   PubMed Web of Science ®Google Scholar
• Sato A, Aonuma K, Watanabe M, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study. Int J Cardiol. 2017;227:424–429. doi:10.1016/j.ijcard.2016.11.019
   PubMed Web of Science ®Google Scholar
• Huang FY, Huang BT, Pu XB, et al. CHADS(2), CHA(2)DS(2)-VASc and R(2)CHADS(2) scores predict mortality in patients with coronary artery disease. Intern Emerg Med. 2017;12(4):479–486. doi:10.1007/s11739-017-1608-x
   PubMed Web of Science ®Google Scholar
• Yao HM, Wan YD, Zhang XJ, et al. Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre. BMJ Open. 2014;4(8):e004892. doi:10.1136/bmjopen-2014-004892
   PubMed Web of Science ®Google Scholar
• Cooper HA, Domanski MJ, Rosenberg Y, et al. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial. Am Heart J. 2004;148(6):1012–1019. doi:10.1016/j.ahj.2004.02.017
   PubMed Web of Science ®Google Scholar
• Cotter G, Cannon CP, McCabe CH, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003;145(4):622–627. doi:10.1067/mhj.2003.6
   PubMed Web of Science ®Google Scholar
• Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345–2353. doi:10.1001/archinte.163.19.2345
   PubMedGoogle Scholar
• Kytö V, Sipilä J, Rautava P. Gender and in-hospital mortality of ST-segment elevation myocardial infarction (from a multihospital nationwide registry study of 31,689 patients). Am J Cardiol. 2015;115(3):303–306. doi:10.1016/j.amjcard.2014.11.001
   PubMed Web of Science ®Google Scholar
• Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–2037. doi:10.1161/01.CIR.102.17.2031
   PubMed Web of Science ®Google Scholar
• Kirigaya H, Kato S, Gyotoku D, et al. Higher CHADS2 score is associated with impaired coronary flow reserve: a study using phase contrast cine magnetic resonance imaging. Int J Cardiol. 2016;221:800–805. doi:10.1016/j.ijcard.2016.07.116
   PubMed Web of Science ®Google Scholar
• Hsu PC, Chiu CA, Chu CY, et al. CHADS2 score and risk of new-onset peripheral arterial occlusive disease in patients without atrial fibrillation: a Nationwide Cohort Study in Taiwan. J Atheroscler Thromb. 2015;22(5):490–498. doi:10.5551/jat.27284
   PubMed Web of Science ®Google Scholar
• Melgaard L, Gorst-Rasmussen A, Lane DA, et al. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015;314(10):1030–1038. doi:10.1001/jama.2015.10725
   PubMed Web of Science ®Google Scholar
• Alraies MC, Darmoch F, Tummala R, et al. Diagnosis and management challenges of in-stent restenosis in coronary arteries. World J Cardiol. 2017;9(8):640–651. doi:10.4330/wjc.v9.i8.640
   PubMedGoogle Scholar
• Alfonso F, Díez-Villanueva P, Rivero F. CHA(2)DS(2)-VAS(C) clinical score to predict in-stent restenosis. Angiology. 2018;69(8):653–656. doi:10.1177/0003319717736159
   PubMed Web of Science ®Google Scholar
• Rampidis GP, Benetos G, Benz DC, et al. A guide for gensini score calculation. Atherosclerosis. 2019;287:181–183. doi:10.1016/j.atherosclerosis.2019.05.012
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-1584
   PubMed Web of Science ®Google Scholar
• Mazzone C, Cioffi G, Carriere C, et al. Predictive role of CHA(2)DS(2)-VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm. Eur J Prev Cardiol. 2017;24(15):1584–1593. doi:10.1177/2047487317726068
   PubMed Web of Science ®Google Scholar
• Soylemez N, Balli M, Koksal F, et al. A new current to the armamentarium: is the CHA2DS2-Vasc-HS score predictive of low left internal mammary artery (lima) flow in patients underwent coronary bypass surgery? Heart Surg Forum. 2021;24(4):E631–E636. doi:10.1532/hsf.3837
   PubMed Web of Science ®Google Scholar
• Rozenbaum Z, Elis A, Shuvy M, et al. CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome. Eur J Intern Med. 2016;36:57–61. doi:10.1016/j.ejim.2016.09.010
   PubMed Web of Science ®Google Scholar
• Maden O, Çakmak Karaaslan Ö, Kanal Y, et al. Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI. Herz. 2022;47(5):456–464. doi:10.1007/s00059-021-05070-x
   PubMed Web of Science ®Google Scholar
• Kim KH, Kim W, Hwang SH, et al. The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation. J Cardiol. 2015;65(2):121–127. doi:10.1016/j.jjcc.2014.04.011
   PubMed Web of Science ®Google Scholar
• Ünal S, Açar B, Yayla Ç, et al. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis. Coron Artery Dis. 2016;27(6):478–482. doi:10.1097/MCA.0000000000000388
   PubMed Web of Science ®Google Scholar
• Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907. doi:10.1016/j.jacc.2010.07.028
   PubMed Web of Science ®Google Scholar
• Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin. 2016;5(2):211–220. doi:10.1016/j.iccl.2015.12.006
   PubMedGoogle Scholar
• Shehadeh N, Raz I, Nakhleh A. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):117. doi:10.1186/s12933-018-0760-6
   PubMedGoogle Scholar
• Luo Y, Cui S, Zhang C, et al. Prognostic role of fasting remnant cholesterol with in-stent restenosis after drug-eluting stent implantation. Int J Gen Med. 2022;15:1733–1742. doi:10.2147/IJGM.S348148
   PubMed Web of Science ®Google Scholar